JOIN US AT DREAMFORCE 2026 — BOOK A MEETING →

Healthcare & Life Sciences

Healthcare buyers expect partners who understand their world. Do your SDRs know each system's strategic priorities?

Healthcare and life sciences buyers operate in a heavily regulated environment with complex organizational structures. They can immediately tell when a rep does not understand their world — and first impressions determine whether you get a second meeting. Q-Pilot ensures every rep shows up with clinical credibility.

NextQuarter
SalesMarketing
Sales Intelligence
Command Center
Accounts
Contacts
Action Board
Q-Pilot Agents
Audio Briefings
Account Planning
360° Account Plans
Notifications
Admin
Sales/Accounts/Q-Pilot Navigator3AM
Account BriefFull ResearchSales Playbook
Ask AnythingMeeting PrepPitch Deck
Exec SummaryInitiativesStakeholdersPlaybookSignalsIntel
Technology Stack
Data Cloud PlatformML InferenceData LakehouseContainer OrchestrationPythonJava
Financial SummaryQ4 FY26✓ 42 sources
Source · 06/2026
Source · 06/2026
Source · 06/2026
SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats

Industry Challenges

What revenue teams face

Regulatory complexity

Healthcare buyers operate in a regulatory environment that affects every purchasing decision. Messaging must be compliance-aware and context-specific. A misstep in positioning does not just lose the deal — it damages the relationship for years.

Complex organizational structures

Health systems, pharma companies, and medical device manufacturers have layered decision-making processes spanning clinical, administrative, procurement, and IT functions. Generic account research cannot map the influence networks that determine buying decisions.

Clinical credibility

Reps selling into healthcare need to demonstrate understanding of clinical priorities, patient outcome metrics, and regulatory mandates — not just business metrics. Generic pitches are dismissed immediately, and healthcare buyers share negative experiences across their networks.

Case Study

Global B2B Pharma Manufacturer

4+ years of continuous partnership. 270+ key accounts managed on the platform. 5 product expansions including Financial Clarity for SKU-level forecasting. 2-year renewal commitment signed — the longest in Next Quarter history.

  1. Sep 2021

    Launch: Platform deployed for strategic account management across 270+ key accounts

  2. Feb 2022

    Measurable Value: Demonstrated ROI across key accounts with improved account coverage and renewal rates

  3. 2023

    Expansion: Added account planning capabilities for cross-sell and upsell identification

  4. Sep 2024

    AI Capabilities: Q-Pilot integration for contextual intelligence across all managed accounts

  5. Dec 2024

    Financial Forecasting: Financial Clarity deployed for SKU-level accuracy across product lines

  6. Oct 2025

    Long-term Commitment: 2-year renewal signed — the longest commitment in company history

  7. Dec 2025

    Full Platform: Complete product suite adoption across sales, marketing, and operations

Buying Committee

Who you need to reach

Chief Medical Officer / Chief Scientific Officer Clinical Decision Maker
VP Procurement / Supply Chain Economic Buyer
Hospital Administrator / System CFO Financial Decision Maker
Director of Pharmacy / Lab Director Technical Evaluator
IT Director / CIO Technical Influencer
Compliance / Regulatory Affairs Gate Keeper

Products you may like

ACCOUNT INTELLIGENCEFirmographicTechnographicIntent SignalsCompetitiveFinancialOrg StructureRelationshipEngagementSales PlaybookDiscovery questions · Objection handlingPitch DeckInitiative-aligned slides · ROI framingMeeting BriefAgenda · Bios · Talking pointsEmail SequencesPersona-grounded multi-touch cadenceAudio BriefAccount intel for the drive over

Q-Pilot for Sales

Learn more →
NextQuarter
SalesMarketing
Sales Intelligence
Command Center
Accounts
Contacts
Action Board
Q-Pilot Agents
Audio Briefings
Account Planning
360° Account Plans
Notifications
Admin
Sales//Account PlanQ-Pilot Navigator3AM
Ask AnythingAccount TeamLaunch Account Review
1KnowUnderstand the account2PlanDefine the strategy3ExecuteTurn plans into action
Account BriefWhitespaceOrg Chart
Account Profile
Account Type
Enterprise
Industry
HQ
Revenue
$3.4B
Executive Summary
Alignment & Use Cases
Aligned Offerings
C-Level Themes
Growth RoadmapNext 4 quarters
Q1Q2Q3Q4
Top InitiativesShowing 1–5 of 10
Active
Active
Active
Active
Planned

Account Growth

Learn more →
demand signalsrevenue plansactuals close the loop
ERPProduction · Supply · SKUs
CRMDeals · Forecast · Actuals

Financial Clarity

Learn more →
Anatomy of one campaignBuilt in under 30 min
44 Target Accounts10 industries · intent-ranked
Tier A9 accounts
1:1 executive plays
55% · $385K
Tier B14 accounts
1:few industry plays
30% · $210K
Tier C21 accounts
1:many digital
15% · $105K
4 Phases · 20 WeeksemailLinkedInwebinarsexec outreach
SetupW1–3
LaunchW4–6
Deep EngagementW7–14
AccelerationW15–20
$3Mqualified pipeline target · 6 qualified opportunities

ABM Suite

Learn more →
"Next Quarter has been our strategic account management platform for over 4 years. The addition of Q-Pilot and Financial Clarity transformed how our reps engage healthcare buyers — they show up with clinical context, organizational mapping, and SKU-level intelligence that no other platform can match."
VP Strategic Accounts
Global B2B Pharma Manufacturer

FAQ

Frequently Asked Questions

How does Next Quarter serve healthcare and life sciences companies? +

Next Quarter provides compliance-aware intelligence, complex organizational mapping, and clinical-context positioning for healthcare sales teams. A global pharma manufacturer has used the platform for 4+ years across 270+ key accounts with 5 product expansions, culminating in a 2-year renewal commitment.

Is Q-Pilot intelligence compliant with healthcare regulations? +

Q-Pilot surfaces publicly available intelligence and contextual insights to help reps understand healthcare organizations’ priorities and challenges. It does not access or process protected health information (PHI). The intelligence is designed to improve sales preparation, not replace clinical or regulatory compliance processes.

How does Financial Clarity support pharma and life sciences forecasting? +

Financial Clarity provides ML-powered forecasting at the SKU level — critical for pharma companies managing complex product portfolios with different revenue recognition timelines, seasonal demand patterns, and production schedules. It translates between ERP production data and CRM pipeline data for 95%+ forecast accuracy.

30 minutes · Real accounts
· Real ROI

See what your team could do with the right intelligence.

We'll show you Q-Pilot running against real accounts, build a playbook live, and give you a custom ROI assessment.